Tumor Endothelial Cell-Specific Drug Delivery System Using Apelin-Conjugated Liposomes

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Kawahara, Hiroki ^a   Naito, Hisamichi ^a   Takara, Kazuhiro ^a   Wakabayashi, Taku ^a   Kidoya, Hiroyasu ^a   Takakura, Nobuyuki ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APELIN; APELIN 13; APELIN 14; APELIN 36; APELIN RECEPTOR; CYSTEINE; LIPOSOME; PROTEIN APJ; RHODAMINE; THIOL GROUP; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SPECIFICITY; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOPLASM; DRUG DELIVERY SYSTEM; ENCAPSULATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MELANOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN TRANSPORT; TARGET CELL; TUMOR CELL; TUMOR MICROENVIRONMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; ENDOTHELIAL CELLS; FEMALE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOSOMES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NIH 3T3 CELLS; RECEPTORS, G-PROTEIN-COUPLED;

MUS;

EID: 84879043063     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065499     Document Type: Article

References (25)

1. Flamme I, Frölich T, Risau W, (1997) Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 173: 206-10.
2. Folkman J, (1971) Isolation of a tumor factor responsible for angiogenesis. J Exp Med 133: 275-88.
3. Siekmann AF, Lawson ND, (2007) Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445: 781-784.
4. Ferrara N, (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 4: 581-611.
5. Shibuya M, Claesson-Welsh L, (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 10: 49-60.
6. Presta LG, Chen H, O'Connor SJ, Chisholm V, Meng YG, et al. (1997) Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 57: 4593-9.
7. Gerber HP, Ferrara N, (2005) Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies. Cancer Res 65: 671-80.
8. Jain RK, (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307: 58-62.
9. Gavard J, Patel V, Gutkind JS, (2008) Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 14: 25-36.
10. Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, et al. (2008) Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 10: 513-26.
11. Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, et al. (2008) Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 10: 527-37.
12. Baffert F, Le T, Sennino B, Thurston G, Kuo CJ, et al. (2006) Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol 290: 547-59.
13. Augustin HG, Koh GY, Thurston G, Alitalo K, (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10: 165-77.
14. Kidoya H, Ueno M, Yamada Y, Mochizuki N, Nakata M, et al. (2008) Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J 27: 522-34.
15. Kidoya H, Naito H, Takakura N, (2010) Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. Blood 115: 3166-74.
16. Kidoya H, Kunii N, Naito H, Muramatsu F, Okamoto Y, et al. (2012) The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy. Oncogene 31: 3254-3264.
17. Fukami A, Iijima K, Hayashi M, Komiyama K, Omura S, (2002) Macrosphelide B suppressed metastasis through inhibition of adhesion of sLe(x)/E-selectin molecules. Biochem Biophys Res Commun 291: 1065-70.
18. Takakura N, Watanabe T, Suenobu S, Yamada Y, Noda T, et al. (2000) A role for hematopoietic stem cells in promoting angiogenesis. Cell 102: 199-209.
19. Lee DK, Ferguson SS, George SR, O'Dowd BF, (2010) The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with beta-arrestin. Biochem Biophys Res Commun 395: 185-9.
20. Heldin CH, Rubin K, Pietras K, Ostman A, (2004) High interstitial fluid pressure- an obstacle in cancer therapy. Nat Rev Cancer 4: 806-13.
21. O'Brien ME, Wigler N, Inbar M, Rosso R, Grischke E, et al. (2004) Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol 15: 440-449.
22. O'Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, et al. (1993) A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136: 355-60.
23. Devic E, Rizzoti K, Bodin S, Knibiehler B, Audigier Y, (1999) Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ. Mech Dev 84: 199-203.
24. Brooks PC, Clark RA, Cheresh DA, (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264: 569-71.
25. Murphy EA, Majeti BK, Barnes LA, Makale M, Weis SM, et al. (2008) Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proc Natl Acad Sci U S A 105: 9343-8.